The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 10 of the 29 sources its claims cite were checked for support.
A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study
Open accessAbstract
Background: Effectiveness of early intensive aphasia rehabilitation after stroke is unknown. The Very Early Rehabilitation for SpEech trial (VERSE) aimed to determine whether intensive aphasia therapy, beginning within 14 days after stroke, improved communication recovery compared to usual care. Methods: Prospective, randomized, single-blinded trial conducted at 17 acute-care hospitals across Australia/New Zealand from 2014 to 2018. Participants with aphasia following acute stroke were randomized to receive usual care (direct usual care aphasia therapy), or one of two higher intensity regimens (20 sessions of either non-prescribed (usual care-plus or prescribed (VERSE) direct aphasia therapy). The primary outcome was improvement of communication on the Western Aphasia Battery-Revised Aphasia Quotient (AQ) at 12 weeks after stroke. Our pre-planned intention to treat analysis combined high intensity groups for the primary outcome. Findings: Among 13,654 acute stroke patients screened, 25% (3477) had aphasia, of whom 25% (866) were eligible and 246 randomized to usual care ( n = 81; 33%), usual care-plus ( n = 82; 33%) or VERSE ( n = 83; 34%). At 12 weeks after stroke, the primary outcome was assessed in 217 participants (88%); 14 had died, 9 had withdrawn, and 6 were too unwell for assessment. Communication recovery was 50.3% (95% CI 45.7–54.8) in the high intensity group ( n = 147) and 52.1% (95% CI 46.1–58.1) in the usual care group ( n = 70; difference −1.8, 95% CI −8.7–5.0). There was no difference between groups in non-fatal or fatal adverse events ( p = 0.72). Interpretation: Early, intensive aphasia therapy did not improve communication recovery within 12 weeks post stroke compared to usual care.
Overview
CoChat Summary
## TL;DR
In this multicenter randomized controlled trial, intensive early aphasia therapy started within 14 days of stroke did not improve communication recovery at 12 weeks compared with usual care. The high-intensity groups received more therapy, but outcomes, adverse events, and secondary measures were not better than control.
## Key findings
- Of 13,654 acute stroke patients screened, 3,477 (25%) had aphasia; 866 (25% of those with aphasia) were eligible, and 246 were randomized to usual care (n=81), usual care-plus (n=82), or VERSE (n=83).
- The primary analysis at 12 weeks found communication recovery of 50.3% (95% CI 45.7–54.8) in the high-intensity group versus 52.1% (95% CI 46.1–58.1) in usual care, a between-group difference of −1.8 (95% CI −8.7 to 5.0; p=0.59).
- The high-intensity groups received a mean of 22.7 h of aphasia therapy over 32 days, compared with 9.5 h over 28 days in usual care; 82% of those assigned to high-intensity therapy received the intervention per protocol.
- There was no difference in non-fatal or fatal adverse events (p=0.72), and the paper reports no statistically significant differences on secondary outcomes or subgroup analyses.
## Methods
- Phase III, prospective, randomized, single-blinded, multicenter trial conducted at 17 acute-care hospitals in Australia and New Zealand, with blinded outcomes at 12 weeks (primary) and 26 weeks post-stroke.
- Included adults >18 years with acute stroke and aphasia of any type within 14 days of onset, with WAB-R Aphasia Quotient <93.7; participants were followed at 45 subacute and community healthcare centers.
- Participants were randomized 1:1:1 to usual care, usual care-plus, or VERSE; the primary intention-to-treat analysis combined the two higher-intensity groups and used a linear mixed model adjusted for baseline WAB-R AQ, baseline NIHSS, and hospital site.
## Limitations
- The paper states there was no no-treatment arm because “inclusion of a no treatment arm was not considered ethical,” so spontaneous recovery could not be separated from treatment effects.
- The paper notes that monitoring other therapies and social interactions was outside the funding scope, and this may have influenced language recovery; this is an evident limitation of the design, as stated in the text.
- The study was conducted in English-speaking participants who required capacity to consent and excluded several groups (e.g., pre-existing aphasia, dementia, inability to participate in English-based therapy), which limits generalizability; this is evident from the eligibility criteria.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
7 Valid · 0 Not valid · 12 Not checked · 23 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Together, these trials3–6 provide compelling evidence to challenge the ‘intensive’ mindset in early stroke language and communication recovery.”
§ A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study > Discussion
What the sources say
- Supportedcites [3] source
The Abstract Conclusion states that four weeks of intensive CLT initiated within 2 weeks of stroke was not more effective than no language treatment and that the results 'exclude a clinically relevant effect of very early cognitive-linguistic treatment on everyday language'. The Discussion (Principal findings) adds that their meta-analysis shows SLT 'whether or not intensive, when started within 4 weeks after stroke onset, is not more effective... than regular, less intensive or deferred treatment', and the Introduction notes the evidence for early intensive CLT is 'frail' with feasibility 'questionable'. This RATS-3 trial therefore is one of the early-stroke trials that challenges the intensive best-practice regime, matching the attributed point; the source's own mild hedges ('lack of unequivocal proof', therapy not redundant) do not contradict the claim's framing. (LLM, conf=0.85)
- Not checked yetcites [4]
- Not checked yetcites [5] source
- Partly supportedcites [6] sourceExperimental — accuracy not yet measured
Our copy of the VERSE paper is a trial design/protocol document: the Introduction and Rationale states the aim and hypotheses ("VERSE aims to determine if intensive aphasia therapy provides greater efficacy... our primary hypothesis is that compared to UC, early intensive aphasia therapy will result in improved communication ability... at 12 weeks post stroke"), and the Discussion (Secondary analyses section) closes with "This trial is designed to test whether the intensive and prescribed VERSE intervention is effective... Since the trial commenced recruitment, 81 patients have been enrolled from 11 hospitals." So the source IS the VERSE very-early intensive aphasia trial the citing sentence pools, but it reports no outcome results and therefore contains no evidence — let alone "compelling evidence" — that challenges the intensive mindset; if anything its stated premise is that intensive very early therapy may enhance recovery. The evidentiary conclusion attributed here would come from later results publications, not this protocol. (LLM, conf=0.72)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Based on benchmarking of aphasia intervention studies, a 5-point change on the WAB-R AQ represents a conservative, clinically meaningful effect. 29”
§ A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study > Methods > Outcomes
What the sources say
- Partly supportedcites [29] sourceExperimental — accuracy not yet measured
The Results report WAB-AQ treatment effects of 5.03 points within groups and 5.05 points between groups. The Discussion says a 5-point measurement benchmark has been framed as clinically meaningful, but does not call a 5-point change conservative; it also notes that measurement error varies substantially with aphasia severity. Thus, the paper supports the approximate benchmark but not an unqualified claim that it is a conservative, clinically meaningful change for every patient. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The more recent RATS-3 trial 3 (N = 153) demonstrated no benefit of early therapy consisting of 24.5 h over four weeks (6.1 h per week) when compared to no therapy in the first month, measured at 4, 12, and 26 weeks post stroke.”
§ A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study > Background
What the sources say
- Partly supportedcites [3] sourceExperimental — accuracy not yet measured
The core attribution is supported: the Abstract/Results report 80 patients allocated to intensive CLT versus 72 controls, a median treatment intensity of 24.5 h in 4 weeks, an adjusted ANELT-A difference of 0.39 (95% CI −2.70 to 3.47, p = 0.805) at 4 weeks, and no significant differences at 3 and 6 months (Methods, Assessments; Results, Compliance). Two attributed details do not match our copy: RATS-3 included 152 patients, not N = 153, and the follow-up points (4 weeks, 3 months, 6 months) were anchored to randomisation, which occurred on average 8 days after stroke onset, not to stroke onset itself (so '4, 12 and 26 weeks post stroke' is off); the per-week figure of 6.1 h is the citing authors' division of 24.5 h by 4 and is not stated (the intended intensity was 28 h in 4 weeks). Note also that the on-treatment analysis did show a significant 4-week benefit for the 23 patients reaching ≥28 h, which the neutral framing omits but does not contradict, since the claim concerns the primary intention-to-treat result. (LLM, conf=0.72)
boostedn = 153- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Evidence from human motor and animal stroke recovery models suggests the first 90 days post stroke is the ‘window of opportunity’ 2 where the greatest potential to harness spontaneous recovery exists. 12”
§ A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study > Background
What the sources say
- Partly supportedcites [2] sourceExperimental — accuracy not yet measured
Our copy supports only the general idea: the 'Timing of treatment...' section states that 'because of the neurovascular remodelling processes activated in response to stroke, a time interval of a few days to months after stroke exists in which neurological recovery presumably is most promising' — hedged, and with no defined endpoint. The specific 'first 90 days' figure and the phrase 'window of opportunity' appear nowhere in our copy (searched: window of opportunity, 90 days, spontaneous improvement, timing). Moreover the same section opens by denying a sharp boundary ('The promotion of brain remodelling and plasticity is not limited to a sharp and well defined therapeutic window'), and 'Benefits of neurorestorative therapies' plus 'Consequences for clinical translation' report success when treatment began days, weeks or months after stroke, 'far into the rehabilitation phase'. So the 90-day delimitation is not attributable to this source. (LLM, conf=0.70)
- Supportedcites [12] source
The Abstract (p.1) frames the review around 'the time course of spontaneous recovery in the first three months after stroke' and interventions 'to enhance recovery from impairment in the first three months after stroke', describing a 'time-limited window of heightened plasticity... early after stroke when most recovery from impairment occurs'. The Human Perspective section (Current Rehabilitation Methods do not Sufficiently Target Impairment) adds that patients achieve about 70% of maximal potential recovery by 3 months, and Current approaches to rehabilitation calls this 'this critical period of spontaneous biological recovery'. One nuance: the paper locates the peak window in animal models at ~4 weeks and notes the human 3-month figure differs for unknown reasons (Comparing the time courses of stroke recovery in animal models and humans), so the 90-day bound is chiefly the human data, but the overall claim of a first-three-months window to harness spontaneous recovery is the paper's stated thesis. (LLM, conf=0.85)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Early, intensive aphasia therapy did not improve communication recovery within 12 weeks post stroke compared to usual care.”
- Also stated in: § Discussion · plain
“We found that 22 h (or an average 5 h per week) of aphasia therapy (regardless of type) delivered over 32 days, showed no benefit over 9.5 h delivered over 28 days (2.3 h per week) for the primary outcome WAB-R AQ at 12 weeks post stroke.”
§ A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study > Abstract > Interpretation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
15 more claims
Create a free account to see all 42 claims and to verify the 19 references still open.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 17
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The app provided 6 components of speech exercises for 1 day based on established behavioral therapies [5,10].”
From Smartphone-Based Speech Therapy for Poststroke Dysarthria: Pilot Randomized Controlled Trial Evaluating Efficacy and Feasibility (2024) · cites this paper as [10]
Experimental — accuracy not yet measured
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · cited 1×
“Baseline assessments were completed by trained staff before randomizing participants using a computer-generated, block randomization sequence (permutated block of six, with 1:1:1 randomization to three groups (UC, UC-Plus, VERSE) to achieve an overall ratio of 1:2 (UC; high intensity therapy, combined UC-Plus and VERS…”
MethodHoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., Altman, D. G., Barbour, V., Macdonald, H., Johnston, M., et al. (2014) · BMJ · doi:10.1136/bmj.g1687 · Cited by 10,548
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Western Aphasia Battery--Revised
Kertesz, A. (2012) · PsycTESTS Dataset · doi:10.1037/t15168-000 · Cited by 1,367
Speech and language therapy for aphasia following stroke
Brady, M. C., Kelly, H., Godwin, J., Enderby, P., & Campbell, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000425.pub4 · Cited by 1,159
(2015) · The Lancet · doi:10.1016/s0140-6736(15)60690-0 · Cited by 789
Clinical Guidelines for Stroke Management 2010
Boddice, G., Brauer, S., Gustafsson, L. A., Kenardy, J. A., & Hoffmann, T. (2010) · Cited by 767
Engelter, S. T., Gostynski, M., Papa, S., Frei, M., Born, C., Ajdacic-Gross, V., Gutzwiller, F., & Lyrer, P. A. (2006) · Stroke · doi:10.1161/01.str.0000221815.64093.8c · Cited by 688 · cited 1×
“We believe the trial sample was representative of a typical population with post-stroke aphasia evidenced by the severity of stroke and aphasia recruited to this trial.(8) Our 7% recruitment rate is consistent with recruitment for acute stroke trials.”
BackgroundGetting Neurorehabilitation Right: What Can Be Learned From Animal Models?
Krakauer, J. W., Carmichael, S. T., Corbett, D., & Wittenberg, G. F. (2012) · Neurorehabilitation and Neural Repair · doi:10.1177/1545968312440745 · Cited by 591 · cited 3×
“Evidence from human motor and animal stroke recovery models suggests the first 90 days post stroke is the ‘window of opportunity’(2) where the greatest potential to harness spontaneous recovery exists.(12) This theory suggests that high frequency repetition should strengthen neural networks and minimize independent ne…”
Background
Research works printed but not linked: 4
- Reinvang I, Engvik H. Norsk Grunntest Afasi, Oslo: Norbok, 1980.
- Sarno MT. Functional communication profile, London: Whurr Publishers, 1969.
- Kaplan EF, Goodglass H, Weintraub S. Boston naming test, 2nd ed. New York, NY: NCS Pearson, 2000.
- Brady MC Ali M VandenBerg K et al. RELEASE: an individual participant data meta-analysis incorporating systematic review and network meta-analysis of complex speech-language therapy interventions for stroke-related aphasia. National Institute for Health Research – Program Grant for Applied Research 2019.
Cited by
Current Approaches to the Treatment of Post-Stroke Aphasia
Fridriksson, J., & Hillis, A. E. (2021) · Journal of Stroke · doi:10.5853/jos.2020.05015 · Cited by 172
“Much like Breitenstein et al.,18 Nouwens et al.,29 and Godecke et al.,30 these preliminary data from POLAR suggest participants with more severe aphasia are less likely to respond to SLT.”
BackgroundResultInfluentialStroke: Molecular mechanisms and therapies: Update on recent developments
Shehjar, F., Maktabi, B., Rahman, Z. A., Bahader, G. A., James, A. W., Naqvi, A., Mahajan, R., & Shah, Z. A. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105458 · Cited by 163
Ischemic Stroke: Pathophysiology and Evolving Treatment Approaches
Majumder, D. (2024) · Neuroscience Insights · doi:10.1177/26331055241292600 · Cited by 130
Kristinsson, S., den Ouden, D., Rorden, C., Newman‐Norlund, R., Neils‐Strunjas, J., & Fridriksson, J. (2022) · Journal of Stroke · doi:10.5853/jos.2022.01102 · Cited by 71
Brazilian practice guidelines for stroke rehabilitation: Part II
Minelli, C., Luvizutto, G. J., Cacho, R. D. O., Neves, L. D. O., Magalhães, S. C. S. A., Pedatella, M. T. A., de Mendonça, L. I. Z., Ortiz, K. Z., Lange, M. C., Ribeiro, P. W., et al. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0042-1757692 · Cited by 92
Metadata
- Authors
- Godecke, E., Armstrong, E., Rai, T., Ciccone, N., Rose, M. L., Middleton, S., Whitworth, A., Holland, A., Ellery, F., Hankey, G. J., Cadilhac, D. A., Bernhardt, J., & on behalf of the VERSE Collaborative Group
- Affiliations
- Edith Cowan University (AU)
- School of Mathematical and Physical Sciences, University of Technology NSW, Broadway, Australia
- La Trobe University (AU)
- Australian Catholic University (AU)
- Curtin University (AU)
- University of Arizona (US)
- The University of Melbourne (AU)
- The University of Western Australia (AU)
- Monash Health (AU)
- Corresponding author
- Godecke, Erin
- ORCID
- Venue
- International Journal of Stroke
- Publisher
- SAGE Publications
- Published
- 2020-10-06
- Volume
- 16
- Issue
- 5
- Pages
- 556-572
- ISSN
- 1747-4930 (ISSN-L)
- 1747-4949
- PMC
- PMC8267088
- OpenAlex
- W3090842330
- Cited by
- 100
- References
- 34
- Citations by year
- 2026: 17 · 2025: 15 · 2024: 12 · 2023: 23 · 2022: 20 · 2021: 12 · 2020: 1
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- International Journal of Stroke (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- UWA Profiles and Research Repository (UWA) (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- Australasian Journal of Paramedicine (submittedVersion, cc-by-nc)
- Figshare (submittedVersion, cc-by-nc)
- Figshare (submittedVersion, cc-by)
- UTS ePRESS (University of Technology Sydney) (submittedVersion, other-oa)
- La Trobe University
- Funders
- Australian Catholic University
- La Trobe University
- University of Melbourne
- Curtin University of Technology
- Edith Cowan University
- Tavistock Trust for Aphasia
- Medical Research Council
- National Health and Medical Research Council (1153236, 1058635, 1083010, 1063761, 1132468)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neurobiology of Language and Bilingualism
- Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
- Health Sciences › Health Professions › Speech and Hearing › Dysphagia Assessment and Management
- Keywords
- aphasia, stroke, aphasia rehabilitation, early rehabilitation, communication recovery, usual care, acute stroke
- MeSH terms
- Stroke Rehabilitation, Aphasia, Humans, Prospective Studies, Speech, Speech Therapy, Treatment Outcome, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study. https://app.cochat.ai/papers/10.1177/1747493020961926
- The paper
- Godecke, E., Armstrong, E., Rai, T., Ciccone, N., Rose, M. L., Middleton, S., Whitworth, A., Holland, A., Ellery, F., Hankey, G. J., Cadilhac, D. A., Bernhardt, J., & on behalf of the VERSE Collaborative Group. (2021). A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study. International Journal of Stroke. https://doi.org/10.1177/1747493020961926
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

